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Abstract
Genes involved in disease that are not common are often difficult to identify; a method that pinpoints them from a small
number of unrelated patients will be of great help. In order to establish such a method that detects recessive genes identical-
by-descent, we modified homozygosity mapping (HM) so that it is constructed on the basis of homozygosity haplotype (HM
on HH) analysis. An analysis using 6 unrelated patients with Siiyama-type a1-antitrypsin deficiency, a disease caused by a
founder gene, the correct gene locus was pinpointed from data of any 2 patients (length: 1.2–21.8 centimorgans, median:
1.6 centimorgans). For a test population in which these 6 patients and 54 healthy subjects were scrambled, the approach
accurately identified these 6 patients and pinpointed the locus to a 1.4-centimorgan fragment. Analyses using synthetic data
revealed that the analysis works well for IBD fragment derived from a most recent common ancestor (MRCA) who existed less
than 60 generations ago. The analysis is unsuitable for the genes with a frequency in general population more than 0.1. Thus,
HM on HH analysis is a powerful technique, applicable to a small number of patients not known to be related, and will
accelerate the identification of disease-causing genes for recessive conditions.
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Introduction
Identification of susceptible genetic loci is of great importance
for understanding the underlying mechanisms of a number of
diseases, and thus aiding the development of their treatment.
Whole-genome association studies using individuals not known to
be related have been very successful for the analysis of common
diseases [1], while linkage-based approaches have identified a
number of genes with large effect sizes [2]. More lately, greater
attention has been directed to diseases that cannot be investigated
using these approaches, either because of the difficulty in collecting
a large number of samples, or in finding a sizeable family with the
disease [3]. Such diseases include those caused by multiple rare
genetic variants or by genes with low penetrance or with effects
that become apparent only in the elderly [4]. For unraveling the
causes of such diseases, there is the need for an approach that is
effective in the context of a small number of patients not known to
be related.
The homozygosity mapping (HM) method was developed to
identify a disease-causing gene through analyses of patients from
inbred families [5]. This principle was later expanded and applied
to patients from outbred families [6,7]. Moreover, the use of SNP
data from genome-wide analyses has increased the sensitivity of
the detection [8,9]. However, because the algorithm employed in
HM is highly vulnerable to genotyping errors, an appropriate
correction for such errors is required [10].
In contrast, the homozygosity haplotype (HH) method [9] is an
imputation-free method for determining haplotypes, because it
uses only a fraction of SNP genotyping data. When a region of
conserved homozygosity haplotype (RCHH) is observed in
different individuals, there is a reasonable possibility that these
individuals share an identical-by-descent (IBD) fragment in 1 or
both strands of the homologous chromosomes. The algorithm is
robust to genotyping errors and thus requires very little or no
correction for genotyping errors.
During a previous study that aimed to identify a disease-causing
gene for amyotrophic lateral sclerosis (MIM 613435) [11], we
encountered 2 unrelated patients who shared the same homozy-
gous mutation in the OPTN gene (MIM 602432). In addition, the
region of DNA encompassing the gene contained a number of
SNPs that were homozygous in both patients (a runs of
homozygous SNPs [RHS] [10]). Further, the RHS was contained
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length of RCHH shared between either of the 2 patients and each
of the 85 control subjects was shorter than 0.9 Mb. We therefore
concluded that these 2 patients are very likely shared the disease-
causing IBD gene [11]. We considered that the reasoning had a
general application and the presence of a long RCHH that
contains an RHS strongly suggested the presence of an IBD
fragment. We then encoded this reasoning into a computer
program, thereby establishing HM on HH analysis. Here, we
show here that this is a powerful method that can identify
susceptible loci by identifying homozygous IBD fragments from a
small number of outbred patients.
Methods
Ethics Statement
This study was approved by the Institutional Review Boards of
Saitama Medical University, Tokyo University, and Juntendo
University. All patients involved in the current study provided
written informed consent.
HM on HH analysis
HM on HH analysis is a combination of HM analysis [5,10]
employing controls and HH analysis [9] employing controls. The
analysis does not presume that the patients are from inbred
families, and can be performed on patients from the general
population. It searches for an RHS overlap that is contained in an
RCHH (see below). A candidate region thus obtained may contain
a recessive disease-causing gene.
Most recent common ancestor (MRCA)
For patients sharing a disease-causing gene, the most recent
common ancestor (MRCA) is the most recent ancestor from whom
they inherited the recessive disease-causing gene (Figure 1A).
Therefore, in the patients, the disease-causing gene is IBD. HM on
HH analysis identifies 2 or more patients who are homozygous for
this gene.
Structure formed by the IBD fragments
The IBD fragments generate characteristic regions in the
genotyping data both in a single patient and between 2 patients.
In a single patient, the overlap of 2 IBD fragments forms an
RHS if its length is greater than the RHS cutoff (Figure 1B) [10].
Between 2 patients, RHSs can form an overlap (RHS overlap,
hereafter). In the RHS overlap, the genotypes of both subjects are
identical, forming an RHS overlap in which 2 subjects share an
identical genotype (RHS overlap IG, hereafter) (Figure 1C). In
addition, the overlap of the ‘‘region in which at least 1 fragment is
derived from the MRCA’’ generates an RCHH if its length is
greater than the RCHH cutoff (Figure 1C) [9]. The RHS overlap
IG is contained in the RCHH, and the structure is hereby called
the RHS overlap IG-RCHH nest. An RHS overlap IG-RCHH
nest may be formed by chance between a patient and a control
due to a coincidence in the SNP genotype. However, the RHS
overlap IG-RCHH nest between the patients is likely to be longer,
both in the size of the RHS overlap IG and in the size of the
RCHH, than that formed by chance between a patient and a
control (Figure 1D). Consequently, if we detect an RHS overlap
IG-RCHH nest between 2 patients and it is longer than any of that
detected between each patient and each control both in the size of
the RHS overlap IG and in the size of the RCHH, the RHS
overlap IG-RCHH nest is likely to suggest the presence of the IBD
fragments in these 2 patients.
HM on HH analysis
HM on HH analysis searches for the RHS overlap IG-RCHH
nest. The analysis is composed of 4 steps. Step 1: HM. The RHSs
are obtained, and the RHS overlaps are selected as candidate
regions for a disease-causing gene (Figure 2A) [10]. Step 2:
Intermediate analysis 2 (IM2). RHS overlap IGs are selected as
candidate regions (Figure 2B). Step 3: Intermediate analysis 3
(IM3). For each SNP position contained in an RHS overlap IG
detected in Step 2, the presence of an RHS overlap IG between a
patient and a control is investigated. When the RHS overlap IG
between the 2 patients is longer in size than any of those between a
patient and a control, it is selected as a candidate region
(Figure 2C). Step 4: HH analysis using controls. The RHS
overlap IG-RCHH nest is determined between 2 patients. For
each SNP position contained in the RHS overlap IG in the RHS
overlap IG-RCHH nest, the presence of an RHS overlap IG-
RCHH nest formed between a patient and a control is
investigated. When the RHS overlap IG between the 2 patients
is longer in length than any of those formed between a patient and
a control, and the RCHH between the 2 patients is longer in
length than any of those formed between a patient and a control,
the RHS overlap IG is selected as a candidate region (Figure 2D).
Parameter values
The parameter values used in the current study were as follows.
The RHS cutoff was 1.2 centimorgans. At this cutoff, the total
length of the regions falsely identified as RHSs was less than
1.5 centimorgans in a genome-wide search [10]. Meanwhile, 8.4%
of the total length of RHSs fail to be identified as RHSs when the
MRCA occurred 20 generations ago; 25%, 40 generations ago;
42%, 60 generations ago; 57%, 80 generations ago, and 69%, 100
generations ago (Figure S1A). Before detecting the RHSs, a
genotyping error correction algorithm was applied, with the
suspected genotyping error rate set at 0.006 [10]. The RCHH
cutoff was 0.0 centimorgans; thus, a match of HH of any length
was considered to be an RCHH.
Human subjects
Patients with Siiyama-type a1-antitrypsin deficiency
(MIM 107400.0039). Siiyama-type a1-antitrypsin deficiency is
a rare recessive disease in Japan [12]. Whole-genome high-density
SNP array genotyping data of 6 patients [10], who were not
related and lived in different areas of Japan, were used in the
current study. All patients provided written informed consent. The
maximal likelihood estimates of the generational distance of the
MRCA for each pair of patients ranged between 5 and 74 (median
61) generations.
Control subjects. The whole-genome high-density SNP
genotyping data of 198 healthy Japanese subjects from the
general population were provided by Prof. Tokunaga, Tokyo
University. Additionally, the SNP genotyping data of 116 JPT
(Japanese in Tokyo) subjects was obtained from the HapMap3
release 28 (http://hapmap.ncbi.nlm.nih.gov/), and data corres-
ponding to the SNPs employed in the Genome-Wide Human SNP
Array 6.0 were extracted. From these 314 subjects, we chose 261
subjects based on the number of SNPs genotyped (the number of
successfully genotyped SNPs for the selected 261 subjects ranged
between 707041 and 903804). These 261 subjects were randomly
assigned as controls (200 subjects), as participants in a test
population (20, 40, or 60 subjects), and a subject who served as the
MRCA. The number of controls used was determined because
200 was the largest round number of controls that could be used.
The number of the patients in the test population was determined
so that the largest test population had 10 times the number of
Homozygosity Mapping on Homozygosity Haplotype
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e25059Figure 1. Structures formed by the fragments derived from the MRCA. (A) The MRCA has a single copy of the disease-causing gene. The
gene is segregated to the patient through both the maternal and paternal lines, and thus the patients are homozygous for the disease-causing gene.
(B) Each of the homologous chromosomes in the patient has a fragment derived from the MRCA. All SNPs in the overlap are homozygous, forming an
RHS [10]. The union of the fragments generates ‘‘a region in which at least 1 fragment is derived from the MRCA.’’ (C) Assume that there are 2
patients. The genotypes of these patients are identical in the RHS overlap, forming an RHS overlap IG. The overlap of ‘‘regions in which at least 1
fragment is derived from the MRCA’’ forms an RCHH [9]. This RCHH therefore contains the RHS overlap IG. This nested structure is hereby called an
RHS overlap IG-RCHH nest. (D) The 2 patients are compared with subjects from a general population (controls). An RHS overlap IG-RCHH nest may be
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believed that this number was suited for demonstrating the
power of the analysis and for enabling an easy interpretation of the
analysis results.
Genotyping
SNP genotyping was performed using the Genome-Wide
Human SNP Array 6.0 (Affymetrix).
Synthetic data
The synthetic genotyping data of a patient who shared 2 IBD
fragments that contain a disease-causing gene were made as
follows: (i) A subject was randomly chosen from the 261 subjects
(see above) to serve as the MRCA. (ii) An SNP was randomly
chosen from an autosomal region and was considered to mark the
position of the disease-causing gene. (iii) The range of the
chromosomal region that contained the SNP and was inherited
by the patient from the MRCA was calculated according to the
Haldane’s Poisson process model [13]. (iv) Step (iii) was repeated
for the second fragment. (v) The genotyping data of the patient
corresponding to the regions that were obtained at steps (iii) and
(iv) were replaced with those of the MRCA.
Variables investigated in HM on HH analysis of a
population
The variables investigated were the number of subjects in the
test population (20, 40, and 60), proportion of patients in the test
population (0, 5, 10, 15, 20, 25, and 30%), generational distance of
the MRCA (20, 40, 60, 80, and 100 generations), and the gene
frequency in the general population (0.0, 0.05, and 0.1). A gene
frequency of 0.0 was considered to represent a rare variant, while
gene frequencies of 0.05 and 0.1 were considered to represent
common variants.
Computer program
The program was written in the Ruby programming language
(http://www.ruby-lang.org/en/) with an extension library written
in the C programming language (http://gcc.gnu.org/). The
program was executed on a MacPro computer that ran on
MacOS X 10.6.
Program
HM on HH program is available at Homozygosity Haplotype
Analysis Web site, http://www.hhanalysis.com
Results
HM on HH analysis in patients with Siiyama-type
a1-antitrypsin deficiency
We tested the performance of HM on HH analysis by using the
SNP genotypes of 6 unrelated patients with Siiyama-type a1-
antitrypsin deficiency, a rare autosomal recessive disease in Japan
caused by a founder mutation of the SERPINA1 gene (MIM
107400) [12]. As controls, we employed the genotypes of 200
Japanese individuals from the general population. The results
obtained after each of the 4 steps that compose HM on HH
analysis are shown for a pair of patients (Figure 3A). After the
completion of the analysis, 2 closely located regions with a total
length of 1.4 centimorgans were identified, 1 of which contained
SERPINA1 (Figure 3A). The results of the other 14 patient-pair
combinations (note that 6C2~15) were similar: each combination
identified candidate regions (total length: 1.2 to 21.8 centimor-
gans, median: 1.6 centimorgans) that contained SERPINA1. Using
the genotyping data of only 2 patients, HM on HH analysis was
able to narrow the position of the disease-causing gene to a very
short chromosomal interval.
HM on HH analysis of a pair of synthetic patients
We further examined the performance of HM on HH analysis
of a pair of patients using synthetic data. We investigated the
MRCA at 5 different generational distances (20, 40, 60, 80 and
100 generations). For each distance, we employed 60 randomly
selected subjects, so that a total of 1770 pairs (60C2~1770) were
constructed. Each pair was investigated for 100 randomly selected
SNP locations, which were assumed to be the location of a disease-
causing gene. The number of trials was thus 177000 (1770
combinations6100 SNPs) for each generational distance.
Detection of the region containing the RHS overlap depended
on the generational distance of the MRCA (Figure 3B). This was
a major limitation of HM on HH analysis: at the HM step, only
RHSs that were longer in length than the RHS cutoff were
detected (Figure S1A) [10]. The detection will be improved by
genotyping more SNPs at a genomewide level, which will allow the
use of a smaller RHS cutoff value (Figure S1B). Once an RHS
overlap was detected at the HM step, HM on HH analysis rarely
failed to track it (Figure 3C): for the MRCA that occurred 20
generations earlier, the RHS overlap was falsely excluded (false
negative) in only 1.5% of the cases, while the falsely included areas
(false positive) were reduced from 61.7 centimorgans after the HM
step to 0.47 centimorgans after the completion of the HH step,
indicating that a small false positive is a prominent feature of HM
on HH analysis. Data for the other generations of the MRCA are
presented in Figure S2.
HM on HH analysis of a population
HM on HH analysis of a population targets a population
containing multiple patients sharing an IBD fragment (Figure 4A).
This simulates a situation in which the population is a collection of
patients with the same disease, and some of the patients share an
IBD gene. We attempt to identify (1) a patient subgroup sharing an
IBD fragment and (2) the chromosomal location of the shared IBD
fragment. Here, we defined the analysis level: at analysis level n,
the computer program searches for a subgroup consisting of n
patients, any pair of which shares an IBD fragment at the same
position on the chromosome (Figure 4B). To achieve the aims (1)
and (2) as stated above, the program identifies (a) the topmost
analysis level at which any subgroup is detected, (b) the members
that are contained in the subgroup, and (c) the position of the IBD
fragment on the chromosome.
First, we investigated the background signal that was detected in
the general population (Figure 4C). For this purpose, we
employed 260 normal subjects. Step (a): 260 normal subjects were
randomly divided into a test population (60 subjects) and 200
controls. Step (b): HM on HH analysis of a population was
performed. Steps (a) and (b) were repeated 500 times. The
histogram of the topmost analysis level, at which any subgroup was
detected (Figure 4D), demonstrated that a subgroup could be
falsely detected (i.e., false positive) in the level 4 analysis and in an
earlier analysis level. Conversely, when a positive result was
formed between patients 1 or 2 and each of the controls due to a coincidence in the SNP genotype. However, the RHS overlap IG-RCHH nest
between the patients is likely to be longer than any of the RHS overlap IG-RCHH nests accidentally formed between a patient and a control.
doi:10.1371/journal.pone.0025059.g001
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sharing an IBD fragment was likely to be detected. Next, we
investigated a test population comprising 6 unrelated patients with
Siiyama-type a1-antitrypsin deficiency and 54 normal subjects
(Figure 4E). A subgroup was detected at level 6 (Figure 4F); the
members of the subgroup were the 6 patients with Siiyama-type
Figure 2. Steps of HM on HH analysis. HM on HH analysis is composed of 4 steps that are serially performed. (A) Homozygosity mapping (HM).
The RHSs are determined for each patient, and the RHS overlaps are obtained. (B) Intermediate analysis 2 (IM2). The RHS overlap IGs are determined.
(C) Intermediate analysis 3 (IM3). The RHS overlap IGs are compared. The RHS overlap IG is selected as a candidate region when the RHS overlap IG is
the longest between the patients. (D) HH analysis using controls. RHS overlap IG-RCHH nests are compared. The RHS overlap IG is selected as a
candidate region when the RHS overlap IG and the RCHH are both the longest between the patients.
doi:10.1371/journal.pone.0025059.g002
Homozygosity Mapping on Homozygosity Haplotype
PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e25059a1-antitrypsin deficiency. The candidate region, 1.2 centimorgans
in width, was located on chromosome 14 and contained the
SERPINA1 gene. HM on HH accurately isolated a subpopulation
that accounted for only 10% of the population and identified the
position of an IBD fragment on the chromosome.
HM on HH analysis of a population containing synthetic
patients
To study the performance of HM on HH analysis in more
detail, we studied test populations containing synthetic patients.
The synthetic patients (5, 10, 15, 20, 25, and 30% of the members
of the population) were homozygous for the IBD fragment derived
from MRCAs at generational distances of 20, 40, 60, 80, and 100
generations. For each combination of these parameters, the
analysis was repeated 100 times by changing the disease-gene
location, which was randomly selected from the SNP positions on
the autosomes. The analysis was considered successful when (1)
only a single candidate region was detected in the topmost level
that detected any subgroup, and (2) the candidate region
contained the locus of a disease-causing gene. The rates of
successful trials (detection rate) were graphed for populations with
60, 40, and 20 subjects (Figure 5A). The results demonstrated
Figure 3. HM on HH analysis of a pair. (A) Analysis of patients 1 and 2 with Siiyama-type a1-antitrypsin deficiency. The position of the disease-
causing gene (SERPINA1) is indicated by an arrow. HM on HH analysis is composed of 4 steps that are sequentially performed. The regions selected after
each step are shown as black bands. The total length of the regions selected at the end was 1.36 centimorgans. (B) The rate at which the RHS overlap
was detected by the HM step (i.e., the first step of the analysis) was the major determinant of HM on HH analysis. The detection rate will be improved by
genotyping more SNPs genomewide. (C) False positives and false negatives for each analysis. False negatives are decreased with the progression of the
analyses. False negatives are very few: 1.5% of the RHS overlap detected by the HM analysis is falsely excluded by HM on HH analysis.
doi:10.1371/journal.pone.0025059.g003
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fragment that accounted for only a small fraction of the
population.
The analysis described above assumed that the frequency of the
allele containing the disease-causing gene was 0.0 in the general
population. However, the disease-causing gene may be a common
variant. We investigated the performance of HM on HH analysis
when the frequency of the disease-causing gene in the general
population was 0.05 or 0.1 (Figure 5B). The results indicated that
the performance was severely degraded for a frequency of 0.1.
HM on HH analysis was considered to work well for a frequency
,0.1. Therefore, the HM on HH analysis targets a recessive gene
that is the cause of a disease, in which less than 1% of the people in
the general population are homozygous for the gene and thus may
suffer from the disease somewhere in their lifetime.
Analysis without utilizing HH information
Analyses similar to HM on HH analysis may be performed by
stopping the analysis after the HM, IM2, or IM3 steps
(Figure 3A). When stopping after either the HM or the IM2,
Figure 4. HM on HH analysis of a population. (A) Targets. Targets of HM on HH analysis of a population are populations containing multiple
subjects sharing an IBD fragment. (B) Analysis level. At the level n analysis, a subgroup of n members, each pair of which shares an IBD fragment at
the same position on the chromosome, are sought. (C) Scheme of the background determination. (D) Background. A subgroup(s) was falsely detected
at level 3, 4, and 5 analyses. (E) A test population. The population is composed of 6 patients with Siiyama-type a1-antitrypsin deficiency (black circles)
and 54 normal subjects (white circles). (F) Result. The horizontal position indicates the location on the autosomes, each of which is aligned from the p
terminal (left side) to the q terminal (right side). A single subgroup was identified at the level 6 analysis, and the candidate region contained the
SERPINA1 gene. The members of the subgroup, which was the output on the computer console and thus is not shown here, were the 6 patients with
Siiyama-type a1-antitrypsin deficiency.
doi:10.1371/journal.pone.0025059.g004
Homozygosity Mapping on Homozygosity Haplotype
PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e25059the program ran out of memory from the explosion in the numbers
of subgroups that resulted from a large amount of false positives.
When stopping after the IM3 step, the detection rate was much
lower than that after the HH analysis, because of a greater amount
of false positives (Figure s3). These results demonstrated that the
small amount of false positives attained by the HH step is
important for the performance of HM on HH analysis of a
population.
Figure 5. HM on HH analysis of a population performed on populations containing synthetic patients. (A) Scheme of the analysis and
Result. The test population is composed of patients homozygous for a gene identical by descent (black circles) and subjects who do not have the
gene (white circles). The horizontal line of each graph indicates the number (percentage) of patients homozygous for the gene in the test population.
(B) Scheme of the analysis and Result for a gene that is widely shared in the general population. The test population is composed of patients
homozygous for a gene identical by descent (black circles), subjects heterozygous for the gene (gray circles), and subjects who do not have the gene
(white circles). In the case that the gene was widely shared in the general population (the frequency of the allele of the disease-causing gene was 0.05
and 0.1), the detection rate was decreased.
doi:10.1371/journal.pone.0025059.g005
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In the current report, we demonstrated that HM on HH is able
to narrow the candidate region for a disease-causing gene to a very
small chromosomal interval either by employing 2 outbred
patients sharing an IBD fragment, or by using a small population
in which 10%# of the patients share an IBD fragment. Haplotype
information obtained from the region that flanks the RHSs was the
component of the HM on HH analysis that enabled them. By
using the HM on HH analysis, genes with a recessive trait are
exploited in the very early stage of a project attempting to identify
a disease-causing gene.
It has been reported that HM is able to identify a candidate
region from as few as 3 inbred patients [5,8]. Although this
number is small, the clinical characteristics often do not provide
information sufficient for selecting 3 patients who may have an
IBD gene. Furthermore, the total length of the candidate regions
detected by HM is usually large [8,11], which necessitate an
enormous effort for an in-depth search of the regions. HM on HH
analysis offers the advantage of being capable of using only 2
patients to obtain a relatively narrow candidate region, typically it
is a few centimorgans in length. This may enable novel strategies
for identifying disease-causing genes. One such strategy is to
collect several patients who are likely to share a fragment IBD,
identify the candidate regions by a pairwise comparison, and
scrutinize all of these regions by high-throughput sequencing [14].
A small number of founder mutations often largely accounts for
the occurrence of a recessive disease or its predisposition. Examples
are a1-antitrypsin deficiency and cystic fibrosis in Europeans
[15,16], and Gaucher disease and Tay-Sachs disease in Ashkenazi
Jews [17]. The cause of the prevalence may be heterozygote
advantage, a founder effect, or genetic drift [17,18]. Whatever is the
cause, this suggests that the predominance of a limited number of
founder mutations is worth taking into consideration in an attempt
to search for disease-causing genes with a recessive trait. HM on
HH analysis is suitable for pursuing the possibility.
The generational distance of the MRCA has a major effect on
the performance of HM on HH analysis. In the analysis of pair of
patients, the effect was large (Figure 3B). In the analysis of
population, the effect was moderate (Figure 5A). Use of arrays
with a greater number of SNPs will accomplish a better
performance (Figure S1B). Data obtained using SNP Array 6.0
were investigated in the current study; they were considered
suitable for the MRCA with a generational distance #60
generations (Figures 3B and 5A). Founder populations that
settled in recent centuries are amenable to the analysis. These
include the French-Canadian population that settled in Quebec in
the 17th century [19,20], or the Icelandic population that was
founded in the 10th century [21], because the generational
distance of the MRCA may be less than 20–60 generations in
many diseases.
Isolated populations may also be suitable for this analysis; in
such population, a single IBD gene from an MRCA existed in a
recent generation may predominate among patients with a specific
disease. In many countries, there may be many geographical areas
in which MRCAs for a disease-causing gene have a generational
distance of 20–60 generations. A small number of patients that
HM on HH analysis requires will make the analysis easily
performable in small populations from such areas.
Inclusion of the subjects who share the IBD fragment degrades
the performance of the analysis. The frequency of the gene in the
control should be less than 0.1, i.e., less than 20% of the control
subjects may be heterozygous for the gene and less than 1% of the
control subjects may be homozygous for the gene. The analysis is
not suitable for the common variants for the common diseases that
are often the targets of the genome-wide association studies.
The calculation time of the HH on HH analysis is short. The
analysis of a pair of patients is completed in a fraction of a second;
the analysis for a test population of 60 subjects is completed in
15 seconds. Theoretically, an analysis of a study population of 60
subjects requires an investigation of 1.15610
18 subgroups.
However, many of the comparison of 2 patients generate a result
without any candidate region, and thus eliminate the need for
investigating any subgroups containing a given pair. A small
amount of false positive of HM on HH analysis enables an
exhaustive search for the subgroups.
We used 200 controls in the current study, but it is possible to
decrease this number with minimal loss in performance. When the
analysis was performed with 100 controls, we found that the
performance was only mildly decreased. Moreover, the Interna-
tional HapMap3 project (see International HapMap project Web
page) has genotyped and released about 100 or more subjects for
each of the 10 ethnic groups, and these data may be used for
controls.
The RHS overlap IG-RCHH nest was selected when both the
length of the RHS overlap IG and the length of the RCHH
between the patients were both at the top. The criteria may be
weakened to ‘‘top 1%,’’ ‘‘top 10%,’’ etc. However, we found that
the condition of ‘‘at the top’’ worked best for almost all cases (data
not shown). The current criterion is thus considered good for HM
on HH analysis.
The RHS cutoff for the Genome-Wide Human SNP Array 6.0
was selected so that the total length of the false-positive RHS was
acceptable (1.5 centimorgans per a patient). The equivalent RHS
cutoff values for other high-density SNP arrays are 0.75 centi-
morgans for the Human Omni2.5 BeadChip (Illumina), 1.1 cen-
timorgans for the Human1M-Duo BeadChip (Illumina), and
1.9 centimorgans for the GeneChip Human Mapping 500K Array
Set (Affymetrix) [10].
In conclusion, HM on HH analysis used genetic information on
both the RHS and the flanking regions, and thus detected the
locus for a recessive, disease-causing genes with a very low
background from a small number of patients. HM on HH analysis
will accelerate the elucidation of the genetic causes of many
diseases.
Supporting Information
Figure S1 Errors in the HM. (A) The false positive rate is the
ratio of the total length of RHSs that are falsely detected along the
entire length of the autosomes. The false negative rate is the ratio
of the total length of the autozygous segments (i.e., chromosomal
regions in which both chromosomal fragments are IBD) that fail to
be detected as RHSs along the total length of the autozygous
segments. The false positive rate is dependent on the kind of high-
density array and thus is shown for each array. 2.5 M, Human
Omni2.5 BeadChip (Illumina); 1 M, Human1M-duo BeadChip
(Illuina); SNP6.0: Genome-Wide Human SNP Array 6.0 (Affyme-
trix); 500K, 500K GeneChips Mapping Array Set (Affymetrix). m:
the age of the MRCA. (B) Detection rates for each array. The
figure corresponds to Figure 3B; this figure summarizes the
theoretical calculation, while the result in Figure 3B is the result
using the actual genotyping data.
(EPS)
Figure S2 Errors in HM on HH for a pair of patients. The data
corresponding to those of Figure 3C for the MRCAs with a
generational distance of 40, 60, 80, and 100 generations.
(EPS)
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Background. The background was observed to a higher analysis
level than that for the HH analysis (compare with Figure 4D). (B)
Detection rate. Positive results obtained at a level 7 analysis or
higher were considered successful. (C) Detection rate. Positive
results obtained at a level 9 analysis or higher were considered
successful. Figures (B) and (C) correspond with those shown in
Figure 5A. In both conditions, the detection rate was lower than
those shown in Figure 5A.
(EPS)
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